Second White Paper Reviews Proposals Made in the President’s Council of Advisors on Science and Technology 2012 Report on Propelling Innovation – Health Subcommittee Schedules Hearing on PCAST for May 20 Continue reading
Category Archives: Advocacy and Regulations
Washington Update for May 2014
The Council of State Bioscience Associations (CSBA) is a confederation of state-based, non-profit trade organizations each governed by its own board of directors. The common mission of the members of the CSBA is to promote public understanding, and to advocate for public policies that support the responsible development of the bioscience industry. These groups are recognized by BIO as affiliate organizations in their respective states. AZBio is Arizona’s Authorized BIO affiliate and a proud member of CSBA.Continue reading
21st Century Cures Initiative Launches to Pick Up the Pace on BioMedical Innovation
A path to 21st century cures being mapped by the Senate Energy and Commerce CommitteeContinue reading
Arizona Governor Signs HB2078, Fair Access to Cancer Treatment Bill, Enacting Cost-Parity for Oral Anticancer Treatments
PHOENIX, 5/1/14 – Arizona Governor Jan Brewer signed House Bill 2078 into law Wednesday, making Arizona the 32nd state in the United States to have cost-parity for oral anticancer drugs. Beginning January 1, 2016, HB2078, sponsored by Representative Heather Carter (LD15), requires health insurance companies with plans that cover intravenous (IV) anticancer treatments and oral anticancer treatments to not discriminate against oral treatments by way of higher co-payments, deductibles or coinsurance.Continue reading
BIO Announces Kay Holcombe to Join as Senior Vice President, Science Policy
HCR 2005 – “Right to Try” Won’t Benefit Patients
While well intentioned, State “Right to Try” bills are fraught with false hope and dangerous side effects.Continue reading
BIO weighs in on the Presidential Budget
Washington, DC (March 5, 2014) – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement in response to President Obama’s FY 2015 budget proposal:Continue reading
Opinion: SB 1062 has dangerous side-effects
“It is difficult to make our material condition better by the best law, but it is easy enough to ruin it by bad laws.”
– Theodore Roosevelt Continue reading
New Survey Reveals Real World Impact of Medical Device Tax
Results Show Substantial Job Loss, Reduction in R&DContinue reading
Industry leaders reach out to CMS on proposed changes to Medicare Part D
Organizations reflecting a wide breadth of companies and organizations representing, among others, multiple healthcare sectors, employers and patients share concerns over the proposed Medicare Part D changes with CMS Administrator.Continue reading